Update: Vitamin D3 and calcium carbonate supplementation for adolescents with HIV to reduce musculoskeletal morbidity and immunopathology (VITALITY trial): study protocol for a randomised placebo-controlled trial - Dzavakwa, Nyasha Veronica; Chisenga, Molly; McHugh, Grace; Filteau, Suzanne; Gregson, Celia Louise; Kasonka, Lackson; Kranzer, Katharina; Mabuda, Hildah Banda; Mujuru, Hilda; Redzo, Nicol; Rowland-Jones, Sarah; Schaible, Ulrich E.; et al. (Current controlled trials in cardiovascular medicine, 2024)
Keywords: Adjuvants; Alfacalcidol; Analysis; Antiretroviral drugs; Bone density; Bones; Calcifediol; Calcium carbonate; Child development; Children; Clinical trials; Comorbidity; Consent; Demographic aspects; Density; Dosage and administration; Drug dosages; Drug therapy; Efavirenz; Fractures; Health aspects; Highly active antiretroviral therapy; HIV; HIV (Viruses); HIV infection; HIV patients; Homeostasis; Human immunodeficiency virus; Infection; Infections; Intervention; Metabolism; Metabolites; Microbiota (Symbiotic organisms); Musculoskeletal diseases; Osteoporosis; Pathogenesis; Prevention; Pubertal delay; Risk factors; Standard scores; Stunting; Teenagers; Testing; Update; Vitamin D; Vitamin D3; Vitamin deficiency; Zimbabwe; Zambia; Sub-Saharan Africa; Africa